Cepheid, Inc. Sustainability Profile
Cepheid, Inc., a leading molecular diagnostics company headquartered in the United States, has been at the forefront of rapid diagnostic testing since its founding in 1996. With a strong presence in North America, Europe, and Asia, Cepheid focuses on developing innovative solutions for infectious disease testing and genetic analysis. The company is renowned for its GeneXpert® system, which offers real-time PCR testing with unparalleled speed and accuracy. This unique platform enables healthcare providers to deliver timely results, significantly improving patient outcomes. Cepheid's commitment to advancing healthcare is reflected in its extensive portfolio of tests for conditions such as tuberculosis, COVID-19, and sexually transmitted infections. Recognised for its pioneering contributions to the diagnostics industry, Cepheid continues to solidify its market position through ongoing innovation and strategic partnerships, making it a trusted name in molecular diagnostics.
DitchCarbon Score
How does Cepheid, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cepheid, Inc.'s score of 62 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cepheid, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Danaher Corporation, which influences its climate commitments and emissions reporting. As part of its corporate family, Cepheid inherits climate initiatives and targets from Danaher Corporation, including those related to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). While specific reduction targets for Cepheid are not detailed, the overarching commitments from Danaher Corporation suggest a focus on sustainability and emissions reduction across its subsidiaries. This includes initiatives aimed at reducing Scope 1, 2, and 3 emissions, although specific figures for Cepheid are not disclosed. In summary, while Cepheid, Inc. does not provide its own emissions data or specific reduction targets, it aligns with the climate strategies set forth by Danaher Corporation, reflecting a commitment to addressing climate change within its operational framework.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 138,341,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 219,166,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
How Carbon Intensive is Cepheid, Inc.'s Industry?
How Carbon Intensive is Cepheid, Inc.'s Location?
Cepheid, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cepheid, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
